Nobody Puts Plasmid In A Corner: Essential Considerations For mRNA Production

Though it is the critical starting material for our mRNA products, the plasmid is one of the most underrated topics of discussion in the industry. This Advancing Live panel discussion featuring CPI's Philip Probert, Sanofi's Nicolas Chaudet, Tune Therapeutics' Tyler Goodwin, and USP's Ben Clarke digs into the current analytical and manufacturing paradigms for plasmid DNA, touching on the advancements and remaining questions surrounding our understanding of plasmid quality and its impact on mRNA quality.